Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 334.75
-25.85 (-7.17%)
At close: Jan 20, 2026
Gujarat Themis Biosyn Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 1,555 | 1,508 | 1,698 | 1,484 | 1,149 | 905.63 | Upgrade | |
Revenue Growth (YoY) | 0.74% | -11.20% | 14.45% | 29.20% | 26.82% | 6.39% | Upgrade |
Cost of Revenue | 608.14 | 593.2 | 687.4 | 573.39 | 181.25 | 168.27 | Upgrade |
Gross Profit | 946.64 | 914.8 | 1,011 | 910.46 | 967.29 | 737.36 | Upgrade |
Selling, General & Admin | 152.67 | 137.35 | 128.68 | 89.42 | 71.99 | 74.2 | Upgrade |
Other Operating Expenses | 87.65 | 80.38 | 95.04 | 76.04 | 307.64 | 249.14 | Upgrade |
Operating Expenses | 318.16 | 271.47 | 259.08 | 191.22 | 401.96 | 340.66 | Upgrade |
Operating Income | 628.48 | 643.33 | 751.75 | 719.25 | 565.33 | 396.7 | Upgrade |
Interest Expense | -1.67 | -2.33 | -1.43 | -0.95 | -6.56 | -5.25 | Upgrade |
Interest & Investment Income | 7.12 | 7.12 | 40.35 | 51.29 | 32.61 | 21.51 | Upgrade |
Currency Exchange Gain (Loss) | 0.53 | 0.53 | 0.23 | - | 0.09 | - | Upgrade |
Other Non Operating Income (Expenses) | 9.21 | 6.73 | 2.45 | 5.06 | -1.13 | -4.26 | Upgrade |
EBT Excluding Unusual Items | 643.67 | 655.38 | 793.34 | 774.65 | 590.35 | 408.7 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.12 | Upgrade |
Pretax Income | 643.67 | 655.38 | 793.34 | 774.65 | 590.35 | 408.82 | Upgrade |
Income Tax Expense | 160.72 | 167.66 | 201.71 | 194.96 | 154.1 | 107.02 | Upgrade |
Net Income | 482.95 | 487.72 | 591.63 | 579.69 | 436.24 | 301.8 | Upgrade |
Net Income to Common | 482.95 | 487.72 | 591.63 | 579.69 | 436.24 | 301.8 | Upgrade |
Net Income Growth | -8.36% | -17.56% | 2.06% | 32.88% | 44.55% | 27.48% | Upgrade |
Shares Outstanding (Basic) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade |
Shares Outstanding (Diluted) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade |
EPS (Basic) | 4.44 | 4.48 | 5.43 | 5.32 | 4.00 | 2.77 | Upgrade |
EPS (Diluted) | 4.44 | 4.48 | 5.43 | 5.32 | 4.00 | 2.77 | Upgrade |
EPS Growth | -8.09% | -17.56% | 2.06% | 32.88% | 44.57% | 27.46% | Upgrade |
Free Cash Flow | -600.86 | -251.22 | -104.32 | 157.74 | 264.16 | 74.73 | Upgrade |
Free Cash Flow Per Share | -5.52 | -2.31 | -0.96 | 1.45 | 2.42 | 0.69 | Upgrade |
Dividend Per Share | 0.670 | 0.670 | 1.000 | 0.720 | 0.800 | - | Upgrade |
Dividend Growth | 301.92% | -33.00% | 38.89% | -10.00% | - | - | Upgrade |
Gross Margin | 60.89% | 60.66% | 59.52% | 61.36% | 84.22% | 81.42% | Upgrade |
Operating Margin | 40.42% | 42.66% | 44.27% | 48.47% | 49.22% | 43.80% | Upgrade |
Profit Margin | 31.06% | 32.34% | 34.84% | 39.07% | 37.98% | 33.32% | Upgrade |
Free Cash Flow Margin | -38.65% | -16.66% | -6.14% | 10.63% | 23.00% | 8.25% | Upgrade |
EBITDA | 692.01 | 684.61 | 775.58 | 737.48 | 580.14 | 414.03 | Upgrade |
EBITDA Margin | 44.51% | 45.40% | 45.67% | 49.70% | 50.51% | 45.72% | Upgrade |
D&A For EBITDA | 63.53 | 41.28 | 23.83 | 18.24 | 14.81 | 17.33 | Upgrade |
EBIT | 628.48 | 643.33 | 751.75 | 719.25 | 565.33 | 396.7 | Upgrade |
EBIT Margin | 40.42% | 42.66% | 44.27% | 48.47% | 49.22% | 43.80% | Upgrade |
Effective Tax Rate | 24.97% | 25.58% | 25.42% | 25.17% | 26.10% | 26.18% | Upgrade |
Revenue as Reported | 1,582 | 1,532 | 1,742 | 1,550 | 1,189 | 938.29 | Upgrade |
Advertising Expenses | - | 0.07 | 0.16 | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.